SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Holtzman who wrote (1446)1/6/2001 9:30:53 PM
From: scaram(o)uche  Read Replies (1) of 1728
 
Go back 104 weeks and they're all up huge.

1. Biotech was all but left for dead, 1/99. The largest influx of capital ever known to the sector, by far, hit in the intervening 104 weeks.

2. INCY closed at 17 15/16 (split adjusted), 1/5/99.

3. Shareholder's equity was $180M, and price:book was approximately 2.9 (very low in its own right).

4. Current shareholder's equity is approximately $600 million, and price:book is approximately 2.2.

5. Year 2000 revenues will be approximately $195M, up 31% from year 1998 revenues of $135M.

6. Two years of productive research were placed under belt -- in-house, at collaborators like CVTX, and at pharma database subscribers.

7. The share price is up 17%.

I'd also beat the drum that you're (very) wrong for ISIP, except for my personal opinions about the company and it's efforts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News